Friday, October 8, 2021

Merck’s New COVID Drug


Merck’s New COVID Drug Is Making News — How Does It Compare to Ivermectin?

In his latest video, John Campbell, Ph.D., compared ivermectin, whose use as a COVID treatment has been widely criticized by mainstream media, with Merck’s new COVID drug, Molnupiravir, which is garnering positive media coverage.

No comments:

Post a Comment